<?xml-stylesheet type='text/xsl' href='rsspretty.xsl' version='1.0'?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <atom:link href="http://www.law360.com/company_articles/389" rel="self" type="application/rss+xml"/>
    <title>Law360: Bayer Group</title>
    <link>http://www.law360.com/</link>
    <description>Latest articles for organization: Bayer Group</description>
    <copyright>Copyright 2009 Portfolio Media, Inc.</copyright>
    <language>en-US</language>
    <image>
      <url>http://www.law360.com/images/headings/logo.gif</url>
      <title>Law360</title>
      <link>http://www.law360.com/</link>
    </image>
    <item>
      <title>Bayer's Motion For JMOL Denied In Modified Rice Case</title>
      <link>http://www.law360.com/articles/135547</link>
      <description>Two weeks into the first bellwether trial in the multidistrict litigation over losses related to Bayer AG's alleged mishandling of genetically modified rice that entered the U.S. supply, a judge has swiftly denied two motions for judgment as a matter of law filed by Bayer and its subsidiaries.</description>
      <guid>http://www.law360.com/articles/135547</guid>
    </item>
    <item>
      <title>Teva Will Appeal Loss In Vigamox Eyecare Patent Suit</title>
      <link>http://www.law360.com/articles/135395</link>
      <description>Teva Pharmaceuticals USA Inc., having come out on the losing end in a three-year infringement struggle with Alcon Inc. over a patent related to the anti-bacterial eye drop drug Vigamox, has said it will keep up the fight in an appeal to the U.S. Court of Appeals for the Federal Circuit.</description>
      <guid>http://www.law360.com/articles/135395</guid>
    </item>
    <item>
      <title>Bayer, GE, Covidien MRI Agents Carry Higher Risk: FDA</title>
      <link>http://www.law360.com/articles/135024</link>
      <description>A U.S. Food and Drug Administration staff review has found that certain gadolinium-based contrast agents used during MRI procedures may pose more of a risk of a fatal skin disease than other agents on the market.</description>
      <guid>http://www.law360.com/articles/135024</guid>
    </item>
    <item>
      <title>JPMorgan, DataTern Resolve Dispute Over Web Patent</title>
      <link>http://www.law360.com/articles/134813</link>
      <description>JPMorgan Chase &amp; Co. and several subsidiaries have reached a settlement with DataTern Inc. in an infringement suit targeting more than a dozen companies over a patent related to database access systems.</description>
      <guid>http://www.law360.com/articles/134813</guid>
    </item>
    <item>
      <title>Norbrook, Boehringer End Dog Drug IP Brawl</title>
      <link>http://www.law360.com/articles/134827</link>
      <description>Boehringer Ingelheim Pharma GmbH &amp; Co. KG has settled a suit it filed against Norbrook Laboratories Ltd. claiming the veterinary pharmaceutical company infringed a patent for Metacam when seeking approval for a generic version of the canine anti-inflammatory.</description>
      <guid>http://www.law360.com/articles/134827</guid>
    </item>
    <item>
      <title>Bayer Seeks To Join Suit Over EPA Pesticide Approval</title>
      <link>http://www.law360.com/articles/134954</link>
      <description>Bayer CropScience AG has asked for permission to join the Natural Resources Defense Council's suit challenging the U.S. Environmental Protection Agency's approval of spirotetramat, a new Bayer pesticide that allegedly harms the nation's dwindling honeybee population.</description>
      <guid>http://www.law360.com/articles/134954</guid>
    </item>
    <item>
      <title>W.Va. Plaintiffs To Fight Baycol MDL Ruling In 8th Circ.</title>
      <link>http://www.law360.com/articles/131328</link>
      <description>A federal appeals court will hear arguments Tuesday in a dispute over whether the judge in charge of multidistrict litigation over the cholesterol-lowering drug Baycol was empowered to enjoin plaintiffs from filing similar product liability class actions against Bayer Corp. in West Virginia.
</description>
      <guid>http://www.law360.com/articles/131328</guid>
    </item>
    <item>
      <title>8th Circ. Upholds Tossing Of Baycol Expert Testimony</title>
      <link>http://www.law360.com/articles/134223</link>
      <description>Marking another win for Bayer AG in the product liability multidistrict litigation over cholesterol drug Baycol, a federal appeals court panel on Friday upheld the exclusion of expert testimony and dismissed the claims of two plaintiffs. </description>
      <guid>http://www.law360.com/articles/134223</guid>
    </item>
    <item>
      <title>WilmerHale Antitrust Pro Named Intel's Top Lawyer</title>
      <link>http://www.law360.com/articles/134198</link>
      <description>Intel Corp. is taking antitrust compliance seriously, and wants enforcement agencies to know it. That's the signal the company is sending by signing a peace pact with Advanced Micro Devices Inc. and naming WilmerHale LLP partner and antitrust expert Douglas Melamed as its general counsel, according to attorneys.</description>
      <guid>http://www.law360.com/articles/134198</guid>
    </item>
    <item>
      <title>Generics Maker Says Drug-Safety Program Gets Abused</title>
      <link>http://www.law360.com/articles/134153</link>
      <description>Teva Pharmaceuticals Ltd. has reportedly complained to the Federal Trade Commission that it has been unable to purchase bulk quantities of certain pharmaceuticals because brand-name drug companies are using a federal drug-safety program to unfairly limit competition.</description>
      <guid>http://www.law360.com/articles/134153</guid>
    </item>
    <item>
      <title>EPA Strikes Back At Bee Activists' Pesticide Claims </title>
      <link>http://www.law360.com/articles/134022</link>
      <description>The U.S. Environmental Protection Agency has admitted that it failed to timely publish certain notices in the Federal Register, but argued that should not be enough to overturn the approval of spirotetramat, a new pesticide marketed by Bayer CropScience AG that allegedly harms the nation's dwindling honeybee population. </description>
      <guid>http://www.law360.com/articles/134022</guid>
    </item>
    <item>
      <title>Wage-And-Hour Issues In The Life Sciences Industry</title>
      <link>http://www.law360.com/articles/132958</link>
      <description>Employers in the life sciences industry may be directly in the path of the growing tsunami of wage-and-hour class actions causing great upheaval and expense in retail, financial services and other industries. It is important to understand the key risk factors for employers in an industry where research personnel, pharmaceutical sales representatives and independent contractors are prevalent, says Joseph P. Breen of Seyfarth Shaw LLP.</description>
      <guid>http://www.law360.com/articles/132958</guid>
    </item>
    <item>
      <title>Bayer CropScience Buys Athenix For $365M</title>
      <link>http://www.law360.com/articles/132424</link>
      <description>Germany-based Bayer CropScience AG has completed its $365 million acquisition of biotechnology company Athenix Corp., a portfolio company of private equity firm Boston Millennia Partners.</description>
      <guid>http://www.law360.com/articles/132424</guid>
    </item>
    <item>
      <title>FDA Says P&amp;G Is Illegally Marketing Vicks Products</title>
      <link>http://www.law360.com/articles/131630</link>
      <description>The U.S. Food and Drug Administration has warned Procter &amp; Gamble Co.'s CEO that the company is illegally marketing two of its Vicks cold and flu products that contain vitamin C, the agency said Friday.</description>
      <guid>http://www.law360.com/articles/131630</guid>
    </item>
    <item>
      <title>Bayer Seeks To Toss Rice Farmers' Damage Claims</title>
      <link>http://www.law360.com/articles/131455</link>
      <description>With the first bellwether trial looming in multidistrict litigation over losses related to genetically modified rice in the long-grain rice industry, Bayer CropScience AG has asked a judge to throw out a group of rice farmers' claims for damages allegedly incurred after the 2008-2009 crop year.</description>
      <guid>http://www.law360.com/articles/131455</guid>
    </item>
    <item>
      <title>Goodyear Needn't Disclose Full Settlement: Judge</title>
      <link>http://www.law360.com/articles/131488</link>
      <description>Goodyear Tire &amp; Rubber Co. only has to partially disclose a settlement with Royal Dutch Shell PLC in a suit alleging price-fixing of engineered rubber components by affiliates of Bayer AG, Dow Chemical Co. and Polimeri Europa SpA, a judge has ruled.</description>
      <guid>http://www.law360.com/articles/131488</guid>
    </item>
    <item>
      <title>Bayer Unit Sues Rivals Over Fungicide Patents</title>
      <link>http://www.law360.com/articles/131190</link>
      <description>Bayer CropScience LP has accused two other environmental companies, Tessenderlo Kerley Inc. and Phoenix Environmental Care LLC, of copying its ingredients for fungicides for grasses, plants and crops and using a brand name that is similar to Bayer's.</description>
      <guid>http://www.law360.com/articles/131190</guid>
    </item>
    <item>
      <title>Barring Pay-For-Delay, Reverse Payment Settlements</title>
      <link>http://www.law360.com/articles/130757</link>
      <description>While no vote is scheduled and final legislation is not in sight, the Preserve Access to Affordable Generic Drugs Act is in alignment with both the U.S. Department of Justice and the Federal Trade Commission positions on pay-for-delay and reverse cash payments. Companies involved in Hatch-Waxman Act Paragraph IV patent litigation should be paying close attention, say Hill B. Wellford and Matthew L. Fedowitz of Bingham McCutchen LLP.</description>
      <guid>http://www.law360.com/articles/130757</guid>
    </item>
    <item>
      <title>Goodyear, Chemical Cos. Battle Over Shell Deal </title>
      <link>http://www.law360.com/articles/130553</link>
      <description>Affiliates of Bayer AG, Dow Chemical Co. and Polimeri Europa SpA have asked a judge to force Goodyear Tire &amp; Rubber Co. to fully disclose a settlement with Royal Dutch Shell PLC in a suit alleging price-fixing of engineered rubber components by the four chemical giants &#8212; a request the tire maker immediately opposed.</description>
      <guid>http://www.law360.com/articles/130553</guid>
    </item>
    <item>
      <title>Bee Activists Ask To Nix Approval Of Bayer Pesticide</title>
      <link>http://www.law360.com/articles/129790</link>
      <description>Advocacy groups have asked a federal judge to overturn the U.S. Environmental Protection Agency&#8217;s approval of spirotetramat, a new pesticide marketed by Bayer CropScience, contending that the agency did not properly take into account the chemical&#8217;s potential to harm dwindling bee populations.
</description>
      <guid>http://www.law360.com/articles/129790</guid>
    </item>
  </channel>
</rss>
